Deutsche Lufthansa AG (LHA)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 6.974 |
|---|---|
| 52-week range | 6.724 – 10.285 |
| Return, 1 month / 3 months | −9.4% / −17.5% |
| Return, 1 year / 3 years | +4.1% / +18.7% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 39.0% |
| Worst drawdown (1 year) | -30.8% |
| Average daily value traded | 34.45M EUR |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Deutsche Lufthansa AG is a German aviation group based in Cologne. Its main business is scheduled passenger air travel, carried out through its own airline brands and partner carriers that serve travellers on domestic, European and long-haul routes. The group also provides aviation services, including aircraft maintenance, repair and overhaul, air cargo transport and catering, which it supplies to airlines and other customers. It operates hub airports in Germany and connects passengers and freight across a broad international network.
Deutsche Lufthansa AG trades under the code LHA on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Deutsche Lufthansa AG (LHA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 6.974 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 395 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.1% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.1% | ||
| From 52-week high | -30.8% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -2.6% | ||
| 12-month return, skipping the last month | 14.9% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 34.45M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −9.4% |
| 3 months | −17.5% |
| 6 months | −2.6% |
| 1 year | +4.1% |
| 3 years | +18.7% |
| 5 years | +45.5% |
Signals
| 50-day / 200-day average | 7.590 / 8.119 |
|---|---|
| Golden / death cross (60 days) | Death, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.185 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | EUR 0.3300 |
| 7 May 2025 | EUR 0.3000 |
| 8 May 2024 | EUR 0.3000 |
| 8 May 2019 | EUR 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.